GET THE APP

Translational Medicine

Translational Medicine
Open Access

ISSN: 2161-1025

Commentary - (2022)Volume 12, Issue 1

A Short Note on Pharmacokinetics

Qing He Zhao* and Li Yan Qiu
 
*Correspondence: Qing He Zhao, Department of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China, Email:

Author info »

Description

Pharmacokinetics (PK) studies how a drug affects an organism, whereas Pharmacodynamics (PD) studies how the drug impacts the organism. As observed in PK/PD models, both have an impact on dosage, benefit, and side effects. The study of the time course of medication absorption, distribution, metabolism, and excretion is known as pharmacokinetics. The application of pharmacokinetic concepts to the safe and effective therapeutic management of medications in a single patient is known as clinical pharmacokinetics. The movement of a drug through the body's biological systems is referred to as pharmacokinetics. This includes processes such as absorption, distribution, bioavailability, metabolism, and elimination.

The absorption, distribution, and elimination (via metabolism and excretion) of medications are all part of the pharmacokinetic process. It is self-evident that pharmacological compounds must overcome numerous structural and metabolic hurdles. Medical professionals can better understand the physical and chemical properties of medications and how they interact with the body by applying pharmacokinetic concepts to particular patients. Models have been built to help people understand the multiple processes that occur when an organism interacts with a chemical component. The multi-compartmental model is the most often utilized approximation to reality; nevertheless, due to the difficulty of adding parameters with that modelling technique, monocompartmental models and, above all, two compartmental models are the most generally employed.

The ADME scheme (sometimes known as LADME if liberation is included as a distinct stage from absorption) refers to the many divisions into which the model is divided:

1. Liberation refers to the process of a medication being released from its pharmacological formulation.

2. Absorption is the process through which a material enters the bloodstream.

3. Dispersion is the dispersion or spread of chemicals throughout the body's fluids and tissues.

4. Metabolism is the acknowledgment of a foreign chemical by the body, as well as the irreversible change of parent molecules into daughter metabolites.

5. Excretion refers to the process of removing chemicals from the body. Some medications can accumulate permanently in bodily tissue in rare situations.

As a result, detailed knowledge of a number of factors are required to fully comprehend the kinetics of a drug, such as the properties of the substances that act as excipients, the characteristics of the appropriate biological membranes and the way that substances can cross them, or the characteristics of the enzyme reactions that inactivate the drug. Pharmacokinetics describes the time course of ADME of xenobiotic in the body using mathematical equations (models), allowing us to better understand, interpret, and even anticipate the nature and magnitude of biological effects (therapeutic or harmful) of xenobiotic. In pharmacokinetics, several techniques are used to characterize the destiny of xenobiotic in the body, including viewing the body as one or more compartments.

All of these ideas can be expressed as mathematical formulas with accompanying graphical representations. The use of these models allows for a better understanding of a molecule's properties, as well as how a specific drug will behave when given information about some of its basic properties, such as its acid dissociation constant, bioavailability and solubility, absorption capacity, and distribution in the body.

Author Info

Qing He Zhao* and Li Yan Qiu
 
Department of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China
 

Citation: Zhao QH, Qiu LY (2022) A Short Note on Pharmacokinetics. Trans Med. 12:252.

Received: 03-Jan-2022, Manuscript No. TMCR-22-16510; Editor assigned: 04-Jan-2022, Pre QC No. TMCR-22-16510 (PQ); Reviewed: 14-Jan-2022, QC No. TMCR-22-16510; Revised: 26-Jan-2022, Manuscript No. TMCR-22-16510 (R); Published: 02-Feb-2022 , DOI: 10.35248/2161-1025.22.12.252

Copyright: © 2022 Zhao QH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top

https://sekillinickyazma.com.tr/